APhM Merchandise is Available!

Check out our newest lineup of merchandise for American Pharmacists Month, including shirts, hoodies, and the popular Stanley tumblers.

Show the collection  

APhA’s Learning Library

We’re excited to announce the launch of the new APhA Learning Library! This new platform will make it easier than ever for you to get the education you need. Read about some key highlights of our new system.

Learn more  

Call for 2024 APhA Election Applications

APhA seeks candidates for the 2024 APhA Election. Applications for Board of Trustees, Academy, and SIG Leadership are accepted through October 2, 2023.

Apply now  

Featured Education

Upcoming Events

Practice Resources

Tools and resources to support your practice

Access Now  


Latest from APhA

View CEO Blog

Two giants in pharmacy: Two important legacies

In the past month, the profession of pharmacy has lost two very prominent leaders; Thomas Temple, longtime executive director of the Iowa Pharmacists Association; and Dominique Jordan, president of the International Pharmaceutical Federation (FIP) and former president of the Swiss Pharmacists Association (pharmaSuisse). I had the good fortune to know both of these gentlemen and I learned lessons from them that I thought would be worth passing on to those who read this blog. This is a tribute to both of their legacies.


APhA, ASHP, and NABP unveil strategies to bolster pharmacy workforce

National pharmacy associations join forces to address pressing challenges facing the profession

WASHINGTON, DC (September 27, 2023) – The American Pharmacists Association (APhA), the American Society of Health-System Pharmacists (ASHP), and the National Association of Boards of Pharmacy (NABP) are pleased to share a new report including actions to implement solutions to improve pharmacy workplace conditions.


Pharmacy news

View all news

CDC recommends RSV vaccine for pregnant individuals

A CDC advisory panel has recommended the use of Pfizer’s bivalent RSVpreF respiratory syncytial virus (RSV) vaccine for pregnant people. The vaccine is designed to protect newborn babies from the respiratory disease.

Higher buprenorphine doses associated with improved retention in treatment for OUD

A new study in JAMA Network Open found that people with OUD who were prescribed a lower dose of buprenorphine were 20% more likely to discontinue treatment compared with those receiving a higher dose.